Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$56.26
Seasonality Move:
-14.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.83 | Sell |
| 20-day SMA: | 59.05 | Sell |
| 50-day SMA: | 48.51 | Buy |
| 200-day SMA: | 44.37 | Buy |
| 8-day EMA: | 23.02 | Buy |
| 20-day EMA: | 10.58 | Buy |
| 50-day EMA: | 4.49 | Buy |
| 200-day EMA: | 1.16 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.24 | Buy |
| Relative Strength Index (14 RSI): | 52.32 | Buy |
| Chaikin Money Flow: | -1682031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.21 - 63.39) | Buy |
| Bollinger Bands (100): | (34.31 - 52.23) | Buy |
CRISPR Therapeutics AG Technical Analysis
| Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 57.68 while CRSP 8-day simple moving average is 63.83, which is a Sell signal.
-
The stock price of CRSP is 57.68 while CRISPR Therapeutics AG 20-day SMA is 59.05, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 48.51 while CRSP share price is 57.68, making it a Buy technically.
-
CRSP stock price is 57.68 and CRISPR Therapeutics AG 200-day simple moving average is 44.37, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $57.68. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5B
Price in USD:
57.68
Share Volume:
3.3M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
71.13
52-Week Low:
30.04
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 57.68 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 57.68 while CRSP 8-day exponential moving average is 23.02, which is a Buy signal.
-
The stock price of CRSP is 57.68 while CRISPR Therapeutics AG 20-day EMA is 10.58, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 4.49 while CRSP share price is 57.68, making it a Buy technically.
-
CRSP stock price is 57.68 and CRISPR Therapeutics AG 200-day simple moving average is 1.16, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.27 per share, and an increase next year of $0.85 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 8.24, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 52.32, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (50.21 - 63.39), which suggest CRISPR Therapeutics AG is a Buy
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (34.31 - 52.23), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.